Press Release Archives
-
Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich
Press Release ArchivesPHILADELPHIA, Pennsylvania, July 3, 2023 — Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced the completion of its divestiture of its Adare Biome business unit, a pioneer in the... Learn More
-
DSM agrees to terms to acquire postbiotics pioneer Adare Biome
Press Release ArchivesHEERLEN, Netherlands — April 19, 2023 Royal DSM, a global science-based leader in health, nutrition and bioscience, announces that it has entered into exclusive negotiations with Adare Pharma Solutions in order to acquire Adare Biome,... Learn More
-
Adare Pharma Solutions Selects Vantage to Lead Major Packaging Facility Upgrade
Press Release ArchivesHILLSBOROUGH, NJ — March 21, 2023 Adare Pharma Solutions, a leading contract development and manufacturing organization, today announced it has selected Vantage Solutions to lead a major upgrade of their pharmaceutical packaging... Learn More
-
Global CDMO Adare Pharma Solutions Harmonizing Quality with Veeva Vault Quality Suite
Press Release ArchivesVault Quality Suite to connect quality processes, documents, and training on a single platform for improved efficiency and collaboration PLEASANTON, CA — Jan. 11, 2023Veeva Systems (NYSE: VEEV) today announced that Adare Pharma... Learn More
-
Adare Pharma Solutions Announces Appointment of Tom Sellig as Chief Executive Officer
Press Release ArchivesSellig Will Drive Enhanced Customer Service and Go-To-Market Strategy LAWRENCEVILLE, New Jersey, January 6, 2022 – Adare Pharma Solutions ("Adare"), a global, technology-driven contract development and manufacturing organization (CDMO),... Learn More
-
Adare Pharma Solutions Acquires Frontida BioPharm to Expand Leading CDMO Offerings
Press Release ArchivesLawrenceville, NJ, December 1, 2021 – Adare Pharma Solutions (“Adare”), a technology-driven contract development and manufacturing organization (CDMO), announced today the acquisition of Frontida BioPharm (“Frontida”), a... Learn More